Bayer Czech Republic - Net Profit Growth

Created with Highcharts 6.0.4%20042005200620072008200920102011201220132014201520162017-1250-1000-750-500-2500250

Bayer CR`s Net Profit Growth reached -39.4 % in 2017. This is 195 % less than in the previous year.

$1.99

Buy Net Profit Growth data for Bayer Czech Republic.

$19.99

Buy all data for Bayer Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Servier Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...           57.1 -38.7 1.42 40.8 -11.4    
... ... ...               39.4 -49.7 15.3 11.2 15.4    
... ... ...               45.3 -31.8 -22.2 -31.2 42.1    
... ...                 321 28.7 -56.9 27.5 96.7    
                    0.860 19.7 4.60 57.3 0.548    
... ...                 137 -79.2 200 -7.25 -43.7    
... ... ...               -50.1 -23.3 248 -29.6 -46.3   ...
... ... ... ...             18.2 -17.9 44.2 -98.2 4,839    
... ... ... ... ... ... ... ... ... ... ... ... 5.92 0.125 16.7    
... ... ...               63.4 -101 187 -585 -1,813